Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America In Vitro Diagnostics (IVD) Market Forecast 2028 By End-Use (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), By Product Type (Reagents & Kits, Instruments), By Test Type (Clinical Chemistry, Immunoassay/ Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: September 2022   |   Report ID: GR1033   |   Delivery: PDF  Request Free Sample

    North America In Vitro Diagnostics Market size exceeded USD 38 billion in 2021 and is estimated to expand at 2.5% CAGR from 2022 to 2028.

    Growing burden of chronic diseases such as diabetes, cancer, COPD, and other ailments has placed immense pressure on global healthcare systems, enhancing product uptake. Since many medical decisions are made with the support of IVD testing, their demand has been rising significantly. Over the past several years, advancements in the field of IVD has provided new tools to support chronic disease diagnosis and treatment. Companies are catering to the need for at-home tests that offer nearly instant results.

    North America In Vitro Diagnostics Market

    Get more details on this report - Request Free Sample PDF

    Moreover, there has been significant rise in infectious disease such as SARS-CoV2 virus. As a result, the demand for in vitro diagnostic kits and reagents for the rapid diagnosis is on the rise. As in-vitro diagnostics involves testing of various biological samples, the outbreak of the COVID-19 pandemic is expected to influence the market outlook. Additionally, people in North American countries have high disposable income and affordability to undergo expensive treatment regimens.

    North America Market, By Product

    The reagents & kits segment accounted for USD 25 billion revenue in 2021, owing to the rising demand for point-of-care diagnostic products and increasing acceptance of self-testing kits. Leading industry participants are receiving regulatory approvals for their innovative products. Becton, Dickinson, and Company, for example, obtained CE-IVD mark for its new molecular diagnostic combination test, for flu, COVID-19, and respiratory syncytial virus in July 2022. Other diagnostic majors, including Abbott have also entered the home-based COVID-19 testing business.

    North America Market, By Test Type

    The immunoassay/immunochemistry segment will depict more than 3% CAGR through 2028, thanks to growing product use in drug testing and oncology. The incidence of cancer is on the rise in the region. To satisfy these growing patient demands, manufacturers are focusing on the development of innovative diagnostic assays and kits for early disease diagnosis. To illustrate, Agilent Technologies Inc. introduced its Enzyme-Linked Immunosorbent Assay (ELISA) kit to the market in February 2021. The novel product is used for the detection of SARS-CoV-2 and immunoglobulin G (IgG) antibodies in human plasma.

    North America Market, By Application

    The North America IVD market revenue from infectious disease application segment will reach USD 15 billion by 2028. Infectious diseases continue to exact a substantial toll on health and health-care resources in North America. Several communicable diseases, including HIV, chronic hepatitis, and other sexually transmitted infections affect millions of individuals in the region.

    Governments are ensuring that scientific and technological advances in vitro diagnostics are well-integrated into the public health system. In this context, in July 2022, the Clinton Health Access Initiative (CHAI) partnered with Wondfo Biotech Company and Med Access to deliver HIV self-test kits for only $1 to the low- and middle-income communities. This renders the solution as the first lowest priced WHO-accredited HIV self-test.

    North America Market, By End-Use

    The diagnostic laboratories segment size will cross USD 20 billion by 2028. The presence of skilled healthcare professionals and consistent improvements in diagnostic-platform technologies are some of the crucial factors driving industry growth. Emergence of the COVID-19 pandemic has resulted in an unprecedent rise in patient volumes, that has led to increased testing demand in diagnostic laboratories.

    North America Market, By Country

    U.S. in vitro diagnostics market size was around USD 35 billion in 2021, attributed to the rising incidence of chronic illnesses in the region. As per the CDC, over six in ten Americans have at least one chronic ailment, such as cancer, heart disease and stroke, or diabetes. These chronic diseases are counted as major causes of disability and death in the nation, resulting in higher healthcare spending.

    Competitive Industry Landscape

    Major players involved in the market include Thermo Fisher Scientific Inc., Abbott, Becton Dickinson & company, BioRad Laboratories, and BioMerieux SA. These companies have adopted a host of marketing strategies such as new product launch, distribution agreements, business collaborations, and acquisitions that have helped them to sustain their market position in an increasingly competitive business sphere.

    Frequently Asked Question(FAQ) :

    What is the worth of North America in vitro diagnostics (IVD) industry?
    The market size for in vitro diagnostics (IVD) in North America was exceeded USD 38 billion in 2021 and it is projected to register a CAGR of more than 2.5% between 2022-2028.
    Why is the demand for IVD reagents & kits growing?
    The reagents & kits segment was over USD 25 billion in 2021 and will increase with the need for point-of-care diagnostic products and self-testing kits.
    How big is the in vitro diagnostics (IVD) market in the U.S.?
    With rising incidence of chronic illnesses in the region, U.S. industry size was valued at more than USD 35 billion in 2021 and will expand due to consistent rise in regional healthcare expenditure.
    Who are the major companies in North America in vitro diagnostics (IVD) landscape?
    The regional market is highly competitive with the presence of major IVD solution providers, including Thermo Fisher Scientific Inc., Abbott, Becton Dickinson & company, BioRad Laboratories, and BioMerieux SA, among a few others.

    Get this research report on North America In Vitro Diagnostics Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]